citric acid, anhydrous has been researched along with Leukemia in 3 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poláková, K | 1 |
| Bennink, JR | 1 |
| Yewdell, JW | 1 |
| Bystrická, M | 1 |
| Bandzuchová, E | 1 |
| Russ, G | 1 |
| Jiménez, TM | 1 |
| Patel, SB | 1 |
| Pineda, AA | 1 |
| Tefferi, A | 1 |
| Owen, WG | 1 |
| Stroncek, DF | 1 |
| Confer, DL | 1 |
| Leitman, SF | 1 |
1 review available for citric acid, anhydrous and Leukemia
| Article | Year |
|---|---|
Peripheral blood progenitor cells for HPC transplants involving unrelated donors.
Topics: Anticoagulants; Antigens, CD34; Blood Cell Count; Blood Component Removal; Bone Marrow Transplantati | 2000 |
2 other studies available for citric acid, anhydrous and Leukemia
| Article | Year |
|---|---|
Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules.
Topics: Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Antigens, Surface; beta 2-Microglo | 2003 |
Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility.
Topics: ABO Blood-Group System; Anticoagulants; Antineoplastic Agents; Blood Component Removal; Blood Donors | 2003 |